Discrimination of Germline EGFR T790M Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer Patients
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-17-1745
Full Text
Open PDFAbstract
Available in full text
Date
September 25, 2017
Authors
Publisher
American Association for Cancer Research (AACR)